Daptomycin
- Product NDC
- 0143-9456
- Requested package NDC
- 0143-9456-01
- 11-digit product format
- 001439456
- Labeler code
- 0143
- Product ID
- 0143-9456_8aa40ade-a628-428b-898c-076d94c40940
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- daptomycin
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- NDA217415
- Marketing category
- NDA
- Marketing start
- 2025-12-11
- Substance
- DAPTOMYCIN
- Active strength
- 350 mg/7mL
- Pharmacologic classes
- Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N217415-001 | DAPTOMYCIN | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | |
| N217415-002 | DAPTOMYCIN | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N217415-001 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | |
| N217415-001 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | |
| N217415-001 | 12629337 | 2043-01-09 | Drug product | 2026-06-10 | |
| N217415-002 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | |
| N217415-002 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | |
| N217415-002 | 12629337 | 2043-01-09 | Drug product | 2026-06-10 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N217415-001 | DAPTOMYCIN | 350MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N217415-002 | DAPTOMYCIN | 500MG/VIAL | POWDER / INTRAVENOUS | RLD, RS | 2023-01-30 | a72a2bbeb626… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N217415-001 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217415-001 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217415-001 | 12629337 | 2043-01-09 | Drug product | 2026-06-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217415-002 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217415-002 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217415-002 | 12629337 | 2043-01-09 | Drug product | 2026-06-10 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N217415-001 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217415-001 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217415-001 | 12629337 | 2043-01-09 | Drug product | 2026-06-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217415-002 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217415-002 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217415-002 | 12629337 | 2043-01-09 | Drug product | 2026-06-10 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217415-001 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217415-001 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217415-002 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217415-002 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217415-001 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217415-001 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217415-002 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217415-002 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217415-001 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217415-001 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217415-002 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217415-002 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217415-001 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217415-001 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217415-002 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217415-002 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217415-001 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217415-001 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217415-002 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217415-002 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217415-001 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217415-001 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217415-002 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217415-002 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217415-001 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217415-001 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217415-002 | 11759497 | 2038-08-28 | Drug product | 2023-10-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217415-002 | 12053502 | 2038-08-28 | U-3981 | 2024-09-04 | 2680178bc6a6… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Daptomycin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DAPTOMYCIN | 350 mg/7mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| NWQ5N31VKK | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 74176769-b22e-4e41-8c56-051e15ec5fea | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 45ca3ac7-6ee8-4e99-92a6-dc0b401e151a | Product name | 1 | 20250724 |
| 223d8260-7a4e-4ebd-9635-845422d6a8ad | Product name | 9 | 20240909 |
| ca803a62-3799-476f-bbc6-024f77cb0320 | Product name | 4 | 20240207 |
| cad85d83-8fb9-49f8-a5a6-a399af412964 | Product name | 1 | 20230922 |
| 8e59a5ed-f224-4156-b534-1ae4d0b6dfd7 | Product name | 1 | 20230721 |
| ea2c89ab-e8f8-425f-9693-c923fa1e1703 | Product name | 1 | 20220929 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9456-01 | Daptomycin | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | 7 | |
| 0143-9456-01 | Daptomycin | 7 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 7 | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Daptomycin | DAPTOMYCIN | Civica, Inc. | 1ae55ae0-d20f-4e15-b4dc-7e45c33f3152 | 2026-04-09 | Warnings, Adverse reactions | 217415 NDA217415 |
| Daptomycin | DAPTOMYCIN | Hikma Pharmaceuticals USA Inc. | 74176769-b22e-4e41-8c56-051e15ec5fea | 2025-12-18 | Warnings, Adverse reactions | 217415 NDA217415 0143-9456-01 0143-9456 00143945601 |
| Daptomycin | DAPTOMYCIN | Xellia Pharmaceuticals USA LLC | 5e1f739a-eb81-43d8-9a14-89f32b7e1ba1 | 2024-05-24 | Warnings, Adverse reactions | 217415 NDA217415 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1996246 | DAPTOmycin 350 MG Injection | PSN | 74176769-b22e-4e41-8c56-051e15ec5fea | 7 |
| 403920 | DAPTOmycin 500 MG Injection | PSN | 74176769-b22e-4e41-8c56-051e15ec5fea | 7 |
| 1996246 | daptomycin 350 MG Injection | SCD | 74176769-b22e-4e41-8c56-051e15ec5fea | 7 |
| 403920 | daptomycin 500 MG Injection | SCD | 74176769-b22e-4e41-8c56-051e15ec5fea | 7 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 0143-9456-01 | 00143945601 | 1 VIAL, SINGLE-USE in 1 CARTON (0143-9456-01) / 7 mL in 1 VIAL, SINGLE-USE | 2025-12-11 | No | No | Current |